By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NGM Biopharmaceuticals, Inc. 

630 Gateway Boulevard

South San Francisco  California  94080-7014  U.S.A
Phone: 650-243-5555 Fax: 650-583-1646


Company News
NGM To Present New Data On NGM282 At The European Association For The Study Of The Liver International Liver Congress 2015 4/20/2015 2:21:37 PM
NGM Announces Positive Phase II Clinical Data In Primary Biliary Cirrhosis Patients For NGM282, A First-In-Class Investigational Medicine 3/24/2015 7:19:41 AM
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO 3/3/2015 6:24:13 AM
NGM Announces Expansion Of Management Team 3/2/2015 7:58:32 AM
How Merck & Co. (MRK)'s R&D Chief Saved NGM Deal With a Juicy Pitch 2/24/2015 6:23:05 AM
Merck & Co. (MRK) Bets $450 Million on Bay Area's NGM 2/23/2015 5:59:08 AM
NGM Biopharmaceuticals, Inc. Locks Down $50 Million Series C 7/18/2013 8:06:39 AM
AstraZeneca PLC (AZN) and NGM Biopharmaceuticals, Inc. Form Diabetes/Obesity Partnership 6/17/2013 7:09:16 AM
NGM Biopharmaceuticals, Inc., Led by Genentech (RHHBY) Vets Levinson and Goeddel, Raises $13.5 Million 5/6/2013 9:33:29 AM
NGM Biopharmaceuticals, Inc., Janssen Pharmaceutical K.K. Form Alliance for Undisclosed Amount 1/3/2013 8:05:32 AM